Literature DB >> 3039142

Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms?

F Lanza, A Fietta, S Spisani, G L Castoldi, S Traniello.   

Abstract

36 unrelated individuals with neutrophil MPO deficiency, (10 totally MPO deficient) were found on screening a population of 148,000 subjects. A further 2 subjects with total and 22 with partial MPO deficiency were identified through family studies. The assessment of neutrophil function, i.e., peroxidase activity, superoxide anion generation, microbicidal activity towards fungi and bacteria, and locomotor behaviour, was carried out in 10 subjects with total and 4 with partial MPO deficiency. We found that the enzyme defect is associated with a marked impairment in the killing of both S. aureus and C. albicans, without affecting microbicidal activity against S. faecalis. There appears to be a high incidence of malignancy in patients with complete MPO deficiency, suggesting a relationship between a defective MPO system and neutrophil-mediated tumor cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039142

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  11 in total

1.  Eosinophil peroxidase deficiency detected by the Technicon H 1 system.

Authors:  F Lanza; G L Castoldi; M Masotti
Journal:  Blut       Date:  1988-03

2.  Inhibition of myeloperoxidase by salicylhydroxamic acid.

Authors:  B Davies; S W Edwards
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

3.  Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

Authors:  Sunisa Kongkiatkamon; Laila Terkawi; Yihong Guan; Vera Adema; Metis Hasipek; Tatiana Dombrovski; Milo Co; Wencke Walter; Hassan Awada; Yvonne Parker; Stephan Hutter; Simona Pagliuca; Carmelo Gurnari; Heesun J Rogers; Manja Meggendorfer; Daniel J Lindner; Torsten Haferlach; Valeria Visconte; Thomas LaFramboise; Babal K Jha; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2022-06-27       Impact factor: 12.883

4.  Decreased luminol-dependent chemiluminescence response of neutrophils to recombinant human tumour necrosis factor in patients with gastric cancer.

Authors:  I A Schepetkin; N V Cherdyntseva; E V Borunov; I L Skutina; S A Naumov
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 5.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

6.  Monocyte esterase deficiency in malignant neoplasia.

Authors:  G M Markey; J A McCormick; T C Morris; H D Alexander; L Nolan; L M Morgan; M E Reynolds; S Edgar; A L Bell; M D McCaigue
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

7.  Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study.

Authors:  F Lanza; A Latorraca; P Musto; L Ferrari; S Moretti; G Zabucchi; M Carotenuto; G L Castoldi
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

8.  Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity.

Authors:  B Mytar; M Siedlar; M Wołoszyn; I Ruggiero; J Pryjma; M Zembala
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Inflammatory events during murine squamous cell carcinoma development.

Authors:  Thais Helena Gasparoto; Carine Ervolino de Oliveira; Luisa Thomazini de Freitas; Claudia Ramos Pinheiro; Rodrigo Nalio Ramos; André Luis da Silva; Gustavo Pompermaier Garlet; João Santana da Silva; Ana Paula Campanelli
Journal:  J Inflamm (Lond)       Date:  2012-11-23       Impact factor: 4.981

10.  Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells.

Authors:  B Davies; S W Edwards
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.